Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

NCT01859858 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DIETARY_SUPPLEMENT: curcumin
DRUG: Irinotecan

Sponsor

UNC Lineberger Comprehensive Cancer Center